Rhumbline Advisers Idera Pharmaceuticals, Inc. Transaction History

Rhumbline Advisers

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 14, 2019	SELL	$2.37 - $3.97 $218,246 - $365,585	-92,087 Closed	0 $0
Q1 2019 May 01, 2019	BUY	$2.33 - $3.79 $117,199 - $190,637	50,300 Added 120.37%	92,087 $235,000
Q4 2018 Jan 31, 2019	BUY	$2.77 - $9.38 $69,086 - $233,946	24,941 Added 148.05%	41,787 $116,000
Q3 2018 Nov 07, 2018	SELL	$5.53 - $11.36 $709,487 - $1.46 Million	-128,298 Reduced 88.39%	16,846 $150,000
Q2 2018 Aug 06, 2018	BUY	$9.92 - $16.96 $1.44 Million - $2.46 Million	145,144 New	145,144 $192,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

Stay updated on Rhumbline Advisers with notifications on news.